<?xml version='1.0' encoding='utf-8'?>
<section article="ghg" article_name="Health - General" number="13-5302" title_number="13" title_name="Miscellaneous Health Care Programs" subtitle_number="53" subtitle_name="Nonoccupational Postexposure Prophylaxis (Npep) Standing Order Program">
  <level label="a">
    <text>There is a Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program.</text>
  </level>
  <level label="b">
    <text>The Program shall:</text>
    <level label="1">
      <text>Authorize a pharmacist who is registered with the Program to dispense nPEP through a standing order in accordance with § 13–5203 of this subtitle; and</text>
    </level>
    <level label="2">
      <text>Operate in accordance with the procedures approved by the Department with the advice and approval of the Board.</text>
    </level>
  </level>
  <level label="c">
    <text>The Department shall adopt regulations:</text>
    <level label="1">
      <text>Necessary for the administration of the Program; and</text>
    </level>
    <level label="2">
      <text>That address the needs of specific populations including victims of sexual assault and pediatric patients.</text>
    </level>
  </level>
  <level label="d">
    <text>The Department may:</text>
    <level label="1">
      <text>Collect fees necessary for the administration of the Program, unless the patient qualifies for nPEP through the Program for Preventing HIV Infection for Rape Victims established under § 11–1008 of the Criminal Procedure Article;</text>
    </level>
    <level label="2">
      <text>Administer the Program and establish a standardized set of guidelines for pharmacists participating in the Program to use in developing and conducting patient education and training on nPEP that includes:</text>
      <level label="i">
        <text>Avoiding exposure to HIV;</text>
      </level>
      <level label="ii">
        <text>Responding to exposure to HIV with the appropriate use of nPEP;</text>
      </level>
      <level label="iii">
        <text>Access to nPEP and the appropriate follow–up after the administration of nPEP; and</text>
      </level>
      <level label="iv">
        <text>Engagement in additional care including:</text>
        <level label="1">
          <text>Access to pre–exposure prophylaxis (PrEP); and</text>
        </level>
        <level label="2">
          <text>Harm reduction programs for patients with continuing risk of exposures; and</text>
        </level>
      </level>
    </level>
    <level label="3">
      <text>Collect and report data on the operation and results of the Program.</text>
    </level>
  </level>
</section>
